[1] |
Wilson SR, Lyshchik A, Piscaglia F, et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI[J]. Abdom Radiol, 2018, 43(1):127-142.
|
[2] |
Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 68(2):723-750.
|
[3] |
Czeczok TW, Van Arnam JS, Wood LD, et al. The almost-normal liver biopsy: presentation, clinical associations, and outcome[J]. Am J Surg Pathol, 2017, 41(9):1247-1253.
|
[4] |
Sookoian S, Pirola CJ. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine[J]. World J Gastroenterol, 2015, 21(3):711-725.
|
[5] |
冯勇,庄一平,韦强,等.肝脏恶性病变经皮穿刺不同活检方式比较[J].临床放射学杂志,2015, 5(5):793-796.
|
[6] |
杜凌遥,唐红.肝占位性病变的常见病因与临床表现[J].中华肝脏病杂志,2017, 25(1):56-60.
|
[7] |
Wong RJ, Aguilar M, Cheung R, et a1. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States[J]. Gastroenterology, 2015, 148(3):547-555.
|
[8] |
张继红,汤天军.超声引导下经皮肝脏穿刺活检术在肝脏占位病变临床诊疗中的实效性评价[J].中国医学创新,2015, 12(10): 141-144.
|
[9] |
Zech CJ, Schwenke C, Endrikat J. Diagnostic efficacy and safety of gadoxetate disodium vs gadobenate dimeglumine in patients with known or suspected focal liver lesions: results of a clinical phase Ⅲ study[J]. Magn Reson Insights, 2019, 12:1178623X19827976.
|
[10] |
陈晓,蔡建强.《原发性肝癌诊疗规范(2017年版)》解读[J/CD].肝癌电子杂志,2017, 4(3):1-5.
|
[11] |
黄伟俊,邱懿德,黄婷,等.超声造影在经皮肺穿刺活检肺周围型病变中的临床研究[J/CD].中华肺部疾病杂志(电子版),2014, 7(1):43-47.
|
[12] |
陈瀚勋,卢敏艳,舒琦,等.超声造影在肝细胞癌和肝局灶性结节增生鉴别诊断中的价值[J].中国普外基础与临床杂志,2015, 22(1):85-87.
|
[13] |
Cao X, Liu Z, Zhou X, et al. Usefulness of real-time contrast-enhanced ultrasound guided coaxial needle biopsy for focal liver lesions[J]. Abdom Radiol, 2019, 44(1):310-317.
|
[14] |
Battaglia V, Cervelli R. Liver investigations: updating on US technique and contrast-enhanced ultrasound (CEUS)[J]. Eur J Radiol, 2017, 96:65-73.
|
[15] |
Kang TW, Lee MW, Song KD, et al. Added value of contrast-enhanced ultrasound on biopsies of focal hepatic lesions invisible on fusion imaging guidance[J]. Korean J Radiol, 2017, 18(1):152-161.
|
[16] |
Kang HJ, Kim JH, Lee SM, et al. Additional value of contrast-enhanced ultrasonography for fusion-guided, percutaneous biopsies of focal liver lesions: prospective feasibility study[J]. Abdom Radiol, 2018, 43(12):3279-3287.
|
[17] |
Rubenthaler J, Paprottka KJ, Hameister E, et al. Contrast-enhanced ultrasound (CEUS) prediction of focal liver lesions in patients after liver transplantation in comparison to histopathology results[J]. Clin Hemorheol Microcirc, 2017, 66(4):303-310.
|
[18] |
Czeczok TW, Van Arnam JS, Wood LD, et al. The almost-normal liver biopsy: presentation, clinical associations, and outcome[J]. Am J Surg Pathol, 2017, 41(9):1247-1253.
|
[19] |
Park HS, Kim YJ, Yu MH, et al. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging[J]. J Ultrasound Med, 2015, 34(3):411-421.
|
[20] |
Ta CN, Kono Y, Eghtedari M, et al. Focal liver lesions: computer-aided diagnosis by using contrast-enhanced US cine recordings[J]. Radiology, 2018, 286(3):1062-1071.
|
[21] |
Bedossa P, Tordjman J, Aron-Wisnewsky J, et al. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity[J]. Gut, 2017, 66(9):1688-1696.
|